Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 002001221447 cql: author exact 000060017536

Add to list
- Journal Article
- A1
- open access
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities

Yasmine Van Caeneghem (UGent) , Stijn De Munter (UGent) , Paola Tieppo (UGent) , Glenn Goetgeluk (UGent) , Karin Weening (UGent) , Greet Verstichel (UGent) , Sarah Bonte (UGent) , Tom Taghon (UGent) , Georges Leclercq (UGent) , Tessa Kerre (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 6(3).
Add to list
The checkpoint for agonist selection precedes conventional selection in human thymus

Greet Verstichel (UGent) , David Vermijlen, Liesbet Martens (UGent) , Glenn Goetgeluk (UGent) , Margreet Brouwer, Nicolas Thiault, Yasmine Van Caeneghem (UGent) , Stijn De Munter (UGent) , Karin Weening (UGent) , Sarah Bonte (UGent) , et al.

(2017) SCIENCE IMMUNOLOGY. 2(8).
Add to list
- Journal Article
- A1
- open access
In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis

Stijn Vanhee (UGent) , Katrien De Mulder (UGent) , Yasmine Van Caeneghem (UGent) , Greet Verstichel (UGent) , Nadine Van Roy (UGent) , Björn Menten (UGent) , Imke Velghe (UGent) , Jan Philippé (UGent) , Dominique De Bleser, Bart Lambrecht (UGent) , et al.

(2015) HAEMATOLOGICA. 100(2). p.157-166
Add to list
- Conference Paper
- C3
Chimeric antigen receptor transgenic, T cell receptor/CD3 negative monospecific T cells generated from cord blood CD34 positive cells

Yasmine Van Caeneghem (UGent) , Glenn Goetgeluk (UGent) , Karin Weening (UGent) , Greet Verstichel (UGent) , Sarah Bonte (UGent) , Tom Taghon (UGent) , Georges Leclercq (UGent) , Fritz Offner (UGent) , Hinrich Abken, Tessa Kerre (UGent) , et al.

(2015) BLOOD. 126(23).
Add to list
In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

SYLVIA SNAUWAERT (UGent) , Greet Verstichel (UGent) , Sarah Bonte (UGent) , Glenn Goetgeluk (UGent) , Stijn Vanhee (UGent) , Yasmine Van Caeneghem (UGent) , Katrien De Mulder (UGent) , Carlo Heirman, Hans Stauss, Miriam HM Heemskerk, et al.

(2014) LEUKEMIA. 28(4). p.830-841
Add to list
- Conference Paper
- C3
In vitro and in vivo functional evaluation of T-cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system

Sarah Bonte (UGent) , SYLVIA SNAUWAERT (UGent) , Glenn Goetgeluk (UGent) , H Stauss, R Stripecke, M Heemskerk, Yasmine Van Caeneghem (UGent) , Greet Verstichel (UGent) , Stijn Vanhee (UGent) , Bart Vandekerckhove (UGent) , et al.

(2014) JOURNAL OF CLINICAL IMMUNOLOGY. 34(suppl. 2). p.S454-S455
Add to list
- Conference Paper
- C3
CMYB expression during human in vitro hematopoiesis

Stijn Vanhee (UGent) , Yasmine Van Caeneghem (UGent) , Katrien De Mulder (UGent) , Imke Velghe (UGent) , Sylvie Taveirne (UGent) , Nadine Van Roy (UGent) , Björn Menten (UGent) , SYLVIA SNAUWAERT (UGent) , Greet Verstichel (UGent) , Melissa Dullaers (UGent) , et al.

(2013) EXPERIMENTAL HEMATOLOGY. 41(8, suppl. 1). p.S33-S33
Add to list
- Conference Paper
- C3
In vitro generation of antigen-specific T-cells from CD34+haematopoietic progenitor cells: a new and promising immunotherapeutic strategy

SYLVIA SNAUWAERT (UGent) , S Van Coppernolle, Greet Verstichel (UGent) , Glenn Goetgeluk (UGent) , Yasmine Van Caeneghem (UGent) , Stijn Vanhee (UGent) , Imke Velghe (UGent) , Jean Plum (UGent) , Tessa Kerre (UGent) and Bart Vandekerckhove (UGent)

(2013) BONE MARROW TRANSPLANTATION. 48(suppl. 2). p.S30-S30
Add to list
- Conference Paper
- C3
Evaluation of the receptor for hyaluronic acid mediated motility as a tumour-specific antigen in AML

SYLVIA SNAUWAERT (UGent) , Stijn Vanhee (UGent) , Yasmine Van Caeneghem (UGent) , Greet Verstichel (UGent) , Glenn Goetgeluk (UGent) , Imke Velghe (UGent) , Bart Vandekerckhove (UGent) and Tessa Kerre (UGent)

(2012) BONE MARROW TRANSPLANTATION. 47(suppl. 1). p.S322-S322
Add to list
- Journal Article
- A1
- open access
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

SYLVIA SNAUWAERT (UGent) , Stijn Vanhee (UGent) , Glenn Goetgeluk (UGent) , Greet Verstichel (UGent) , Yasmine Van Caeneghem (UGent) , Imke Velghe (UGent) , Jan Philippé (UGent) , Zwi N Berneman, Jean Plum (UGent) , Tom Taghon (UGent) , et al.

(2012) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 97(10). p.1539-1547

Academic Bibliography

Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities

The checkpoint for agonist selection precedes conventional selection in human thymus

In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis

Chimeric antigen receptor transgenic, T cell receptor/CD3 negative monospecific T cells generated from cord blood CD34 positive cells

In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

In vitro and in vivo functional evaluation of T-cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system

CMYB expression during human in vitro hematopoiesis

In vitro generation of antigen-specific T-cells from CD34+haematopoietic progenitor cells: a new and promising immunotherapeutic strategy

Evaluation of the receptor for hyaluronic acid mediated motility as a tumour-specific antigen in AML

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Contents

Support

Contact